Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Beyond Tumor Size, Toward Meaningful Patient Outcomes-Resisting RECIST.

This Viewpoint evaluates the present relevance of Response Evaluation Criteria in Solid Tumors (RECIST) as cancer therapeutics have evolved beyond cytotoxic chemotherapy in assessing treatment outcomes.

C. Nabhan, V. Subbiah · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.